Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

WuXi PharmaTech and DNAnexus Form Genomic Cloud Partnership; WuXi Invests $15 Million

publication date: Apr 22, 2015
WuXi PharmaTech, the China-US CRO/CMO, deepened its commitment to genomics by making a $15 million investment in DNAnexus, a California company with a cloud-based genomic informatics and data management platform. WuXi and DNAnexus will partner to allow web-based access to the genomic services of another WuXi subsidiary, WuXi NextCode Genomics, providing NextCode's proprietary database infrastructure along with its clinical and research tools on the DNAnexus cloud. The partnership helps WuXi accomplish one of its major goals: to create an open access platform that offers all of its CRO services to researchers anywhere in the world. More details....

Stock Symbol: (NYSE: WX)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here